| Literature DB >> 23182634 |
Gabriele Siciliano1, Costanza Simoncini, Annalisa Lo Gerfo, Daniele Orsucci, Giulia Ricci, Michelangelo Mancuso.
Abstract
In mitochondrial myopathies with respiratory chain deficiency impairment of energy cell production may lead to in excess reactive oxygen species generation with consequent oxidative stress and cell damage. Aerobic training has been showed to increase muscle performance in patients with mitochondrial myopathies. Aim of this study has been to evaluate, in 7 patients (6 F e 1M, mean age 44.9 ± 12.1 years) affected by mitochondrial disease, concomitantly to lactate exercise curve, the occurrence of oxidative stress, as indicated by circulating levels of lipoperoxides, in rest condition and as effect of exercise, and also, to verify if an aerobic training program is able to modify, in these patients, ox-redox balance efficiency. At rest and before training blood level of lipoperoxides was 382.4 ± 37.8 AU, compared to controls (318.7 ± 63.8; P<0.05), this corresponding to a moderate oxidative stress degree according to the adopted scale. During incremental exercise blood level of lipoperoxides did not increase, but maintained significantly higher compared to controls. After an aerobic training of 10 weeks the blood level of lipoperoxides decreased by 13.7% at rest (P<0.01) and 10.4%, 8.6% and 8.5% respectively at the corresponding times during the exercise test (P=0.06). These data indicate that, in mitochondrial patients, oxidative stress occurs and that an aerobic training is useful in partially reverting this condition.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23182634 PMCID: PMC3526792 DOI: 10.1016/j.nmd.2012.10.005
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296
Characteristics of mitochondrial patients.
| Patient | Age/sex | Molecular defect | CK (U/L) | PRE-tr rPOmax (% pnPOmax) | PRE-tr rest lactate (mmol/L) | PRE-tr rest lipoperoxides (AU) |
|---|---|---|---|---|---|---|
| 1. | 52/F | Multiple deletion | 104 | 60 | 2.84 | 441 |
| 2. | 55/F | Multiple deletion | 120 | 60 | 1.60 | 405 |
| 3. | 34/F | Multiple deletion | 54 | 70 | 1.93 | 371 |
| 4. | 28/M | Single deletion | 346 | 70 | 2.43 | 377 |
| 5. | 44/F | Single deletion | 284 | 60 | 3.10 | 378 |
| 6. | 39/F | Single deletion | 352 | 60 | 1.70 | 323 |
| 7. | 62/F | Single deletion | 111 | 50 | 1.58 | 389 |
Abbreviations: CK = creatin kinase; PRE-tr = pre-training; rPOmax = real maximum power output; %pnPOmax = percentage of predicted normal maximal power output; AU = arbitrary units.
Lipoperoxide levels (AU) during PRE-tr and POST-tr exercise test and in controls.
| Basal | 40% of pnPOmax | rPOmax | Recovery | |
|---|---|---|---|---|
| pt. 1 | 441 | 393 | 403 | 395 |
| pt. 2 | 405 | 393 | 403 | 395 |
| pt. 3 | 371 | 375 | 370 | 362 |
| pt. 4 | 377 | 398 | 394 | 380 |
| pt. 5 | 378 | 365 | 387 | 381 |
| pt. 6 | 316 | 325 | 335 | 322 |
| pt. 7 | 389 | 402 | 415 | 393 |
| Average | 382.4 | 378.7 | 386.7 | 375.4 |
| St. dev. (±) | 37.8 | 27.1 | 26.9 | 26.3 |
| Average | 318.7 | 326.6 | 334.4 | 324.4 |
| St. dev. (±) | 63.8 | 65.9 | 73.1 | 66.5 |
| Reference range 250–320 | ||||
| pt. 1 | 407 | 419 | 398 | 400 |
| pt. 2 | 303 | 311 | 407 | 392 |
| pt. 3 | 310 | 313 | 315 | 305 |
| pt. 4 | 291 | 296 | 298 | 289 |
| pt. 5 | 334 | 341 | 346 | 338 |
| pt. 6 | 323 | 336 | 346 | 325 |
| pt. 7 | 342 | 359 | 364 | 355 |
| Average | 330.0 | 339.3 | 353.4 | 343.4 |
| St. dev. (±) | 38.3 | 41.1 | 40.1 | 41.8 |
Fig. 1Lactate kinetics in MM [at PRE- and POST-tr (training)] and controls during incremental exercise test.
Fig. 2Lipoperoxide kinetics in MM [at PRE- and POST-tr (training)] and controls during incremental exercise test and correlation in MM (bottom right corner) between rest values of blood lactate and lipoperoxides, both before and after aerobic training.